Current Portfolio
EQT invests in good companies with a mission to help them develop into great companies.
EQT invests in good companies with a mission to help them develop into great companies.
Company | Sector | Fund | Market | Entry |
|---|---|---|---|---|
| FoRx Therapeutics | Life Sciences | LSP 6 | Switzerland | 2019 |
| Fundamental VR | Life Sciences | LSP HEF 2 | United Kingdom | 2022 |
| HotSpot Therapeutics | Life Sciences | LSP 7 | United States | 2021 |
| Illuminoss | Life Sciences | LSP HEF 1 | United States | 2012 |
| Immunic | Life Sciences | LSP 5 | Germany | 2016 |
| Innovative Molecules | Life Sciences | LSP 6 | Germany | 2021 |
| iStar Medical | Life Sciences | LSP HEF 2 | Belgium | 2019 |
| Kinaset | Life Sciences | LSP 7 | United States | 2026 |
| Luma Vision | Life Sciences | LSP HEF 2 | Ireland & Germany | 2020 |
| Merus | Life Sciences | LSP 4 | Netherlands | 2010 |
| MinervaX | Life Sciences | LSP 7 | Denmark | 2023 |
| Mosanna Therapeutics | Life Sciences | LSP 7 | Switzerland | 2024 |
| Muna Therapeutics | Life Sciences | LSP Dementia Fund | Denmark | 2021 |
| Neurent Medical | Life Sciences | LSP HEF 2 | Ireland | 2020 |
| Neuros Medical | Life Sciences | LSP 7 | United States | 2025 |
| Neuros Medical | Life Sciences | EQT HE 3 | United States | 2025 |
| NewAmsterdam Pharma | Life Sciences | LSP Dementia Fund | Netherlands | 2021 |
| Nkarta | Life Sciences | LSP 6 | United States | 2019 |
| Nobi | Life Sciences | LSP HEF 2 | Belgium | 2022 |
| Nobi | Life Sciences | LSP Dementia Fund | Belgium | 2022 |
| Noema Pharma | Life Sciences | LSP 7 | Switzerland | 2024 |
| Nouscom | Life Sciences | LSP 5 | Switzerland | 2015 |
| Nua Surgical | Life Sciences | EQT HE 3 | Ireland | 2024 |
| Oculis | Life Sciences | LSP 7 | Switzerland | 2022 |
| Onera Health | Life Sciences | EQT HE 3 | Netherlands | 2024 |